Carolina BioOncology Institute

Carolina BioOncology Institute (CBOI) is a cancer therapy and research center located in Huntersville, North Carolina. The company employs 40 people and generates an annual revenue of $11 million. CBOI operates as an independent, dedicated Phase I cancer center, serving as the only one of its kind on the East Coast. CBOI specializes in early phase immunotherapy trials, offering a range of services to cancer patients. The center has conducted over 100 early phase clinical trials and has treated nearly 4,000 patients. CBOI also serves as a regional referral hub for Phase I access in the community setting. CBOI's unique business model incorporates BioCytics, its internal research and manufacturing organization. BioCytics focuses on rapidly developing cell therapies using innovative processes and specialized equipment. CBOI's fully integrated capabilities encompass basic and translational research, process development, cGMP manufacturing, clinical development, regulatory affairs, USP, CLIA/COLA, and operations. For more information about Carolina BioOncology Institute, please visit their website at carolinabiooncology.org.